BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Big Executive Pay Raises at EnteroMedics (ETRMD) a Year After They Took Significant Cuts


3/22/2012 8:25:55 AM

Minneapolis / St. Paul Business Journal by Ed Stych, Web Producer

Pay was up nearly five times for CEO, more than four times for CFO. They both took significant pay cuts the year before.

Tracking the pay of Minnesota’s business leaders

Mark Knudson

CEO

EnteroMedics Inc. (Nasdaq: ETRM)

Headquarters: Roseville

Business: Makes an implantable anti-obesity medical device

Total pay

2011: $2.45 million, up 380 percent

2010: $510,000

2009: $1.75 million

Base salary

2011: $345,000

2010: $337,000

Bonus

2011: None

2010: None

Incentive pay

2011: $160,000

2010: $169,000

Stock awards

2011: None

2010: None

Option awards

2011: $1.94 million

2010: None

Change to value of pension

2011: None

2010: None

Other compensation

2011: $5,000

2010: $5,000

Total compensation for other highly-compensated executives:

Greg Lea, chief financial officer: $1.56 million, up 317 percent

Adrianus (Jos) Donders, senior vice president of research and advanced development: $567,000, up 61 percent Katherine Tweden, vice president of clinical and regulatory: $768,000, up 131 percent

Notes

Data comes from documents filed with the U.S. Securities and Exchange Commission.




   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES